Olio Labs

Active, new domain

Combination therapeutics for the world's toughest diseases

What it does

Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.

How it has moved

  • new domain

    The site moved to oliolabs.com, same company.

Next to it in Healthcare and bio · AI-driven combination therapeutics discovery

  • Aperture BioTechstars TS 2023

    Aperture Bio

  • Junction BioscienceY Combinator W24

    AI Hypothesis Engine for Molecular Discovery

  • Serinus BiosciencesY Combinator S22

    Combinations therapy by rational design

  • b12 LabsY Combinator S25

    Making hard molecules for Pharma and Biotech

  • Sequence BioY Combinator S19

    Discovering the true signals of disease to power life-changing drugs.

  • Opal TherapeuticsTechstars TS 2024

    Opal Therapeutics | Advance Women's Health Today

  • ParcelBioY Combinator W24

    Elevated mRNA for transformative medicines.

  • Velorum TherapeuticsY Combinator W24

    Breakthrough medicines unlocking the biology of heme